GlobalData Expects New Novartis Heart Failure Drug to Reach $1.9 Billion ... PharmaLive (press release) (subscription) LONDON, UK (GlobalData), 20 June 2013 - Following a launch scheduled for 2015 for the treatment of Chronic Heart Failure (CHF), Novartis' novel combination drug LCZ-696 will rapidly dominate the global CHF therapeutics sector and mark a drug ... |
